# Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

> **NCT02302365** · — · COMPLETED · sponsor: **Terumo BCT** · enrollment: 43 (actual)

## Conditions studied

- Leukocytosis

## Interventions

- **DEVICE:** Spectra Optia® Apheresis System

## Key facts

- **NCT ID:** NCT02302365
- **Lead sponsor:** Terumo BCT
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302365, "Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02302365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*